Palvella Therapeutics, Inc. Interest Income (Expense), Nonoperating, Net
Palvella Therapeutics, Inc. (PVLA) reported Interest Income (Expense), Nonoperating, Net of $169.00 thousand for the 3-month period ending 2024-09-30, per its 10-Q filed 2024-11-13.
Financial Statements › Income Statement › Other Income
us-gaap:InterestIncomeExpenseNonoperatingNet · last filed 2024-11-13
- Palvella Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2024-09-30 was $169.00K, a 69.22% decline year-over-year.
- Palvella Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2024-06-30 was $201.00K, a 58.98% decline year-over-year.
- Palvella Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2024-03-31 was $240.00K, a 32.77% decline year-over-year.
- Palvella Therapeutics, Inc. interest income (expense), nonoperating, net for the quarter ending 2023-12-31 was $455.00K, a 29.63% increase year-over-year.
- Palvella Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2023 was $1.85M, a 156.73% increase from fiscal 2022.
- Palvella Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2022 was $721.00K, a 17925.00% increase from fiscal 2021.
- Palvella Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2021 was $4.00K, a 99.22% decline from fiscal 2020.
- Palvella Therapeutics, Inc. interest income (expense), nonoperating, net for fiscal 2020 was $511.00K, a 70.19% decline from fiscal 2019.
| Period end | Interest Income (Expense), Nonoperating, Net 3 month | Interest Income (Expense), Nonoperating, Net 3 month as first filed | Interest Income (Expense), Nonoperating, Net 6 month | Interest Income (Expense), Nonoperating, Net 6 month as first filed | Interest Income (Expense), Nonoperating, Net 9 month | Interest Income (Expense), Nonoperating, Net 9 month as first filed | Interest Income (Expense), Nonoperating, Net 12 month | Interest Income (Expense), Nonoperating, Net 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | $169.00K 10-Q · filed 2024-11-13 | $370.00K derived: sum of 2 quarters · filed 2024-11-13 | $610.00K 10-Q · filed 2024-11-13 | $1.06M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2024-06-30 | $201.00K 10-Q · filed 2024-08-14 | $441.00K 10-Q · filed 2024-08-14 | $896.00K derived: sum of 3 quarters · filed 2024-08-14 | $1.45M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2024-03-31 | $240.00K 10-Q · filed 2024-05-15 | $695.00K derived: sum of 2 quarters · filed 2024-05-15 | $1.24M derived: sum of 3 quarters · filed 2024-11-13 | $1.73M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-12-31 | $455.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $1.00M derived: sum of 2 quarters · filed 2024-11-13 | $1.49M derived: sum of 3 quarters · filed 2024-11-13 | $1.85M 10-K · filed 2024-03-29 | ||||
| 2023-09-30 | $549.00K 10-Q · filed 2024-11-13 | $1.04M derived: sum of 2 quarters · filed 2024-11-13 | $1.40M 10-Q · filed 2024-11-13 | $1.75M derived: sum of 4 quarters · filed 2024-11-13 | ||||
| 2023-06-30 | $490.00K 10-Q · filed 2024-08-14 | $847.00K 10-Q · filed 2024-08-14 | $1.20M derived: sum of 3 quarters · filed 2024-08-14 | $1.44M derived: sum of 4 quarters · filed 2024-08-14 | ||||
| 2023-03-31 | $357.00K 10-Q · filed 2024-05-15 | $708.00K derived: sum of 2 quarters · filed 2024-05-15 | $949.00K derived: sum of 3 quarters · filed 2024-05-15 | $1.08M derived: sum of 4 quarters · filed 2024-05-15 | ||||
| 2022-12-31 | $351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $592.00K derived: sum of 2 quarters · filed 2024-03-29 | $724.00K derived: sum of 3 quarters · filed 2024-03-29 | $721.00K 10-K · filed 2024-03-29 | ||||
| 2022-09-30 | $241.00K 10-Q · filed 2023-11-14 | $373.00K derived: sum of 2 quarters · filed 2023-11-14 | $370.00K 10-Q · filed 2023-11-14 | $364.00K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $132.00K 10-Q · filed 2023-08-10 | $129.00K 10-Q · filed 2023-08-10 | $123.00K derived: sum of 3 quarters · filed 2023-08-10 | $127.00K derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$3.00K 10-Q · filed 2023-05-11 | -$9.00K derived: sum of 2 quarters · filed 2023-05-11 | -$5.00K derived: sum of 3 quarters · filed 2023-05-11 | -$2.00K derived: sum of 4 quarters · filed 2023-05-11 | ||||
| 2021-12-31 | -$6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | -$2.00K derived: sum of 2 quarters · filed 2023-03-31 | $1.00K derived: sum of 3 quarters · filed 2023-03-31 | $4.00K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $4.00K 10-Q · filed 2022-11-04 | $7.00K derived: sum of 2 quarters · filed 2022-11-04 | $10.00K 10-Q · filed 2022-11-04 | $18.00K derived: sum of 4 quarters · filed 2022-11-04 | ||||
| 2021-06-30 | $3.00K 10-Q · filed 2022-08-04 | $6.00K 10-Q · filed 2022-08-04 | $14.00K derived: sum of 3 quarters · filed 2022-08-04 | $69.00K derived: sum of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | $3.00K 10-Q · filed 2022-05-11 | $11.00K derived: sum of 2 quarters · filed 2022-05-11 | $66.00K derived: sum of 3 quarters · filed 2022-05-11 | $195.00K derived: sum of 4 quarters · filed 2022-05-11 | ||||
| 2020-12-31 | $8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-02 | $63.00K derived: sum of 2 quarters · filed 2022-03-02 | $192.00K derived: sum of 3 quarters · filed 2022-03-02 | $511.00K 10-K · filed 2022-03-02 | ||||
| 2020-09-30 | $55.00K 10-Q · filed 2021-11-02 | $184.00K derived: sum of 2 quarters · filed 2021-11-02 | $503.00K 10-Q · filed 2021-11-02 | $885.00K derived: sum of 4 quarters · filed 2021-11-02 | ||||
| 2020-06-30 | $129.00K 10-Q · filed 2021-08-05 | $448.00K 10-Q · filed 2021-08-05 | $830.00K derived: sum of 3 quarters · filed 2021-08-05 | $1.21M derived: sum of 4 quarters · filed 2021-08-05 | ||||
| 2020-03-31 | $319.00K 10-Q · filed 2021-05-17 | $701.00K derived: sum of 2 quarters · filed 2021-05-17 | $1.08M derived: sum of 3 quarters · filed 2021-05-17 | $1.53M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | $382.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-31 | $759.00K derived: sum of 2 quarters · filed 2021-03-31 | $1.21M derived: sum of 3 quarters · filed 2021-03-31 | $1.71M 10-K · filed 2021-03-31 | ||||
| 2019-09-30 | $377.00K 10-Q · filed 2020-11-04 | $826.00K derived: sum of 2 quarters · filed 2020-11-04 | $1.33M 10-Q · filed 2020-11-04 | $1.80M derived: sum of 4 quarters · filed 2020-11-04 | ||||
| 2019-06-30 | $449.00K 10-Q · filed 2020-08-10 | $955.00K 10-Q · filed 2020-08-10 | $1.43M derived: sum of 3 quarters · filed 2020-08-10 | $1.93M derived: sum of 4 quarters · filed 2020-08-10 | ||||
| 2019-03-31 | $506.00K 10-Q · filed 2020-05-11 | $977.00K derived: sum of 2 quarters · filed 2020-05-11 | $1.48M derived: sum of 3 quarters · filed 2020-05-11 | $2.14M derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $471.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-13 | $975.00K derived: sum of 2 quarters · filed 2020-03-13 | $1.64M derived: sum of 3 quarters · filed 2020-03-13 | $1.96M 10-K · filed 2020-03-13 | ||||
| 2018-09-30 | $504.00K 10-Q · filed 2019-11-12 | $1.17M derived: sum of 2 quarters · filed 2019-11-12 | $1.49M 10-Q · filed 2019-11-12 | $1.64M derived: sum of 4 quarters · filed 2019-11-12 | ||||
| 2018-06-30 | $662.00K 10-Q · filed 2019-08-09 | $987.00K 10-Q · filed 2019-08-09 | $1.14M derived: sum of 3 quarters · filed 2019-08-09 | $1.14M derived: sum of 4 quarters · filed 2019-08-09 | ||||
| 2018-03-31 | $325.00K 10-Q · filed 2019-05-10 | $477.00K derived: sum of 2 quarters · filed 2019-05-10 | $477.00K derived: sum of 3 quarters · filed 2019-05-10 | $477.00K derived: sum of 4 quarters · filed 2019-05-10 | ||||
| 2017-12-31 | $152.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $152.00K derived: sum of 2 quarters · filed 2019-03-18 | $152.00K derived: sum of 3 quarters · filed 2019-03-18 | $152.00K 10-K · filed 2019-03-18 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2018-11-07 | $96.00 10-Q · filed 2017-11-13 | $0.00 derived: sum of 2 quarters · filed 2018-11-07 | $0.00 10-Q · filed 2018-11-07 | $263.00 10-Q · filed 2017-11-13 | |||
| 2017-06-30 | $0.00 10-Q · filed 2018-08-09 | $67.00 10-Q · filed 2017-08-11 | $0.00 10-Q · filed 2018-08-09 | $167.00 10-Q · filed 2017-08-11 | ||||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-10 | $100.00 10-Q · filed 2017-05-15 | ||||||
| 2016-12-31 | $2.00K 10-K · filed 2018-03-15 | $2.32K 10-K · filed 2017-03-30 | ||||||
| 2015-12-31 | -$180.42K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-30 | -$180.42K derived: sum of 2 quarters · filed 2017-03-30 | -$180.47K derived: sum of 3 quarters · filed 2017-03-30 | -$184.65K 10-K · filed 2017-03-30 | ||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | -$53.00 derived: sum of 2 quarters · filed 2016-11-10 | -$4.22K 10-Q · filed 2016-11-10 | |||||
| 2015-06-30 | -$53.00 10-Q · filed 2016-08-11 | -$4.22K 10-Q · filed 2016-08-11 | ||||||
| 2015-03-31 | -$4.17K 10-Q · filed 2016-05-12 | |||||||
| 2014-12-31 | -$2.65M 10-K · filed 2016-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |